The FDA has approved the use of Gozellix, a PSMA-PET imaging agent, to help detect prostate cancer using gallium-68 ...
A consortium of Austrian research groups from the University of Vienna, MedUni Vienna and Technikum Wien, together with ...
The PSMA-PET imaging agent will be used for patients who have suspected metastasis and those with suspected cancer recurrence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback